These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15960427)

  • 21. Effect of vitamin D3 supplementation on upper respiratory tract infections in healthy adults: the VIDARIS randomized controlled trial.
    Murdoch DR; Slow S; Chambers ST; Jennings LC; Stewart AW; Priest PC; Florkowski CM; Livesey JH; Camargo CA; Scragg R
    JAMA; 2012 Oct; 308(13):1333-9. PubMed ID: 23032549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of recurrent lower urinary tract infections by long-term administration of fosfomycin trometamol. Double blind, randomized, parallel group, placebo controlled study.
    Rudenko N; Dorofeyev A
    Arzneimittelforschung; 2005; 55(7):420-7. PubMed ID: 16080282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and Immunological Benefits of OM-85 Bacterial Lysate in Patients with Allergic Rhinitis, Asthma, and COPD and Recurrent Respiratory Infections.
    Koatz AM; Coe NA; Cicerán A; Alter AJ
    Lung; 2016 Aug; 194(4):687-97. PubMed ID: 27117798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immune preparation IRS-19 in the treatment of inflammation in the upper respiratory tracts].
    Gunchikov MV; Vinnikov AK
    Vestn Otorinolaringol; 2001; (1):40. PubMed ID: 11247247
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevention of recurrent respiratory tract infections in children using a ribosomal immunotherapeutic agent: a clinical review.
    Bousquet J; Fiocchi A
    Paediatr Drugs; 2006; 8(4):235-43. PubMed ID: 16898854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized, placebo-controlled, double-blinded, single-centre, phase IV trial to assess the efficacy and safety of OM-85 in children suffering from recurrent respiratory tract infections.
    Esposito S; Bianchini S; Bosis S; Tagliabue C; Coro I; Argentiero A; Principi N
    J Transl Med; 2019 Aug; 17(1):284. PubMed ID: 31443716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The bacterial lysate Lantigen B reduces the number of acute episodes in patients with recurrent infections of the respiratory tract: the results of a double blind, placebo controlled, multicenter clinical trial.
    Braido F; Melioli G; Candoli P; Cavalot A; Di Gioacchino M; Ferrero V; Incorvaia C; Mereu C; Ridolo E; Rolla G; Rossi O; Savi E; Tubino L; Reggiardo G; Baiardini I; di Marco E; Rinaldi G; Canonica GW; ; Accorsi C; Bossilino C; Bonzano L; DiLizia M; Fedrighini B; Garelli V; Gerace V; Maniscalco S; Massaro I; Messi A; Milanese M; Peveri S; Penno A; Pizzimenti S; Pozzo T; Raie A; Regina S; Sclifò F
    Immunol Lett; 2014 Dec; 162(2 Pt B):185-93. PubMed ID: 25445613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of a polyvalent bacterial lysate in children with recurrent respiratory tract infections.
    Ruah SB; Ruah C; van Aubel A; Abel S; Elsasser U
    Adv Ther; 2001; 18(4):151-62. PubMed ID: 11697018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
    Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
    Evid Based Child Health; 2013 Jul; 8(4):1297-371. PubMed ID: 23877944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial.
    Do NT; Ta NT; Tran NT; Than HM; Vu BT; Hoang LB; van Doorn HR; Vu DT; Cals JW; Chandna A; Lubell Y; Nadjm B; Thwaites G; Wolbers M; Nguyen KV; Wertheim HF
    Lancet Glob Health; 2016 Sep; 4(9):e633-41. PubMed ID: 27495137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of upper respiratory tract infections with broncho-vaxom++: a therapeutic alternative to chemotherapy?].
    Tarchalska-Kryńska B; Zawisza E; Rewerski W
    Otolaryngol Pol; 1994; 48(5):435-40. PubMed ID: 7808749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibiotic use and bacterial complications following upper respiratory tract infections: a population-based study.
    Cars T; Eriksson I; Granath A; Wettermark B; Hellman J; Norman C; Ternhag A
    BMJ Open; 2017 Nov; 7(11):e016221. PubMed ID: 29146635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The administration of a polyvalent mechanical bacterial lysate in elderly patients with COPD results in serological signs of an efficient immune response associated with a reduced number of acute episodes.
    Ricci R; Palmero C; Bazurro G; Riccio AM; Garelli V; Di Marco E; Cirillo C; Braido F; Canonica GW; Melioli G
    Pulm Pharmacol Ther; 2014 Feb; 27(1):109-13. PubMed ID: 23792312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prulifloxacin versus levofloxacin in the treatment of respiratory and urinary tract infections: a multicentre, double-blind, randomized controlled clinical trial.
    Chen Y; Yang H; Lu G; Wu X; Huang W; Wu Y; Lv X; Wu G; Zhang G; Li Q; Sun Y
    Chemotherapy; 2012; 58(3):249-56. PubMed ID: 22890091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Rengalin, a New Efficacious and Safe Antitussive Agent. Results of a Randomized, Comparative, Multicenter Clinical Trial in Patients with Acute Respiratory Tract Infections].
    Akopov AL; Aleksandrova EB; Il'kovich MM; Petrov DV; Trofimov VI
    Antibiot Khimioter; 2015; 60(1-2):19-26. PubMed ID: 26168681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic prescribing patterns of French GPs for upper respiratory tract infections: impact of fusafungine on rates of prescription of systemic antibiotics.
    Fagnani F; German-Fattal M
    Am J Respir Med; 2003; 2(6):491-8. PubMed ID: 14719988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prospective placebo-controlled double-blind study using a bacterial lysate in infections of the respiratory tract and ENT region in children].
    Schaad UB; Farine JC; Fux T
    Helv Paediatr Acta; 1986 May; 41(1-2):7-17. PubMed ID: 3755127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prevention of infections of the respiratory tract in children with RU 41740].
    Bonfils P
    Presse Med; 1988 Jul; 17(28):1450-2. PubMed ID: 2971185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of OM-85 BV in children suffering from recurrent respiratory tract infections and subnormal IgG subclass levels.
    Del-Río-Navarro BE; Luis Sienra-Monge JJ; Berber A; Torres-Alcántara S; Avila-Castañón L; Gómez-Barreto D
    Allergol Immunopathol (Madr); 2003; 31(1):7-13. PubMed ID: 12573204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short courses of daily prednisolone during upper respiratory tract infections reduce relapse frequency in childhood nephrotic syndrome.
    Abeyagunawardena AS; Thalgahagoda RS; Dissanayake PV; Abeyagunawardena S; Illangasekera YA; Karunadasa UI; Trompeter RS
    Pediatr Nephrol; 2017 Aug; 32(8):1377-1382. PubMed ID: 28341877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.